FTC Refunds Consumers for Supplements with Fraudulent Claims

The Federal Trade Commission (FTC) is mailing 16,596 checks, totaling more than $750,000, to consumers who bought NeuroPlus or BioTherapex, two deceptively marketed supplements from Health Research Laboratories, according to a press release.

The checks will reach their recipients by the end of December. The average refund amount is $44.34.

NeuroPlus was deceptively marketed using claims it could protect the brain against Alzheimer’s disease and dementia, reverse memory loss, and improve memory and cognitive performance. BioTherapex was falsely advertised to treat arthritis, relieve joint and back pain, and cause significant weight loss. The complaint alleged that the claims for both products are false or unsubstantiated.

The order settling the charges required the defendants to pay $800,000 to provide refunds to consumers. Those who bought NeuroPlus will be fully refunded. Consumers who bought BioTherapex will receive a refund of almost 15% of the purchase price.